| Dutasteride | Approved Investigational | AKR1C3 | 8644 |
upregulated | Dutasteride results in increased expression of AKR1C3 mRNA | 10p15.1 | |
| Dutasteride | Approved Investigational | AR | 367 |
upregulated | Dutasteride results in increased expression of AR mRNA | Xq12 | |
| Dutasteride | Approved Investigational | CALR | 811 |
downregulated | Dutasteride results in decreased expression of CALR mRNA | 19p13.13 | |
| Dutasteride | Approved Investigational | CCND1 | 595 |
upregulated | Dutasteride results in increased expression of CCND1 mRNA | 11q13.3 | |
| Dutasteride | Approved Investigational | CYP11B2 | 1585 |
upregulated | Dutasteride results in increased expression of CYP11B2 mRNA | 8q24.3 | |
| Dutasteride | Approved Investigational | DHCR24 | 1718 |
downregulated | Dutasteride results in decreased expression of DHCR24 mRNA | 1p32.3 | |
| Dutasteride | Approved Investigational | EAF2 | 55840 |
downregulated | Dutasteride results in decreased expression of EAF2 mRNA | 3q13.33 | |
| Dutasteride | Approved Investigational | ERBB2 | 2064 |
upregulated | Dutasteride results in increased expression of ERBB2 mRNA | 17q12 | |
| Dutasteride | Approved Investigational | HSD17B1 | 3292 |
upregulated | Dutasteride results in increased expression of HSD17B1 mRNA | 17q21.2 | |
| Dutasteride | Approved Investigational | HSD17B3 | 3293 |
upregulated | Dutasteride results in increased expression of HSD17B3 mRNA | 9q22.32 | |
| Dutasteride | Approved Investigational | KLK2 | 3817 |
downregulated | Dutasteride results in decreased expression of KLK2 mRNA | 19q13.33 | |
| Dutasteride | Approved Investigational | KLK3 | 354 |
downregulated | Dutasteride results in decreased expression of KLK3 mRNA | 19q13.33 | |
| Dutasteride | Approved Investigational | SOS1 | 6654 |
upregulated | Dutasteride results in increased expression of SOS1 mRNA | 2p22.1 | |
| Dutasteride | Approved Investigational | SRD5A1 | 6715 |
downregulated | Dutasteride results in decreased expression of SRD5A1 mRNA | 5p15.31 | |
| Dutasteride | Approved Investigational | SRD5A2 | 6716 |
downregulated | Dutasteride results in decreased expression of SRD5A2 mRNA | 2p23.1 | |
| Dutasteride | Approved Investigational | VCAM1 | 7412 |
upregulated | Dutasteride results in increased expression of VCAM1 mRNA | 1p21.2 | |
| Dydrogesterone | Approved Investigational Withdrawn | AKR1C1 | 1645 |
downregulated | Dydrogesterone results in decreased expression of AKR1C1 mRNA | 10p15.1 | |
| Dydrogesterone | Approved Investigational Withdrawn | AKR1C1 | 1645 |
upregulated | Dydrogesterone results in increased expression of AKR1C1 mRNA | 10p15.1 | |
| Dydrogesterone | Approved Investigational Withdrawn | AKR1C2 | 1646 |
downregulated | Dydrogesterone results in decreased expression of AKR1C2 mRNA | 10p15.1 | |
| Dydrogesterone | Approved Investigational Withdrawn | AKR1C3 | 8644 |
downregulated | Dydrogesterone results in decreased expression of AKR1C3 mRNA | 10p15.1 | |
| Dydrogesterone | Approved Investigational Withdrawn | HSD17B2 | 3294 |
downregulated | Dydrogesterone results in decreased expression of HSD17B2 mRNA | 16q23.3 | |
| Dydrogesterone | Approved Investigational Withdrawn | PGR | 5241 |
downregulated | Dydrogesterone results in decreased expression of PGR mRNA | 11q22.1 | |
| Dydrogesterone | Approved Investigational Withdrawn | SRD5A1 | 6715 |
downregulated | Dydrogesterone results in decreased expression of SRD5A1 mRNA | 5p15.31 | |
| Econazole | Approved | CYP3A4 | 1576 |
upregulated | Econazole results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Edetic acid | Approved Investigational Vet Approved | ESR1 | 2099 |
upregulated | Edetic Acid results in increased expression of ESR1 mRNA | 6q25.1-q25.2 | |